HOPA Now podcast

Conversations we need to have about Precision Oncology

11/3/2026
0:00
37:58
Rewind 15 seconds
Fast Forward 15 seconds

Precision medicine in oncology holds a lot of promise for personalized treatment - and requires a lot of collaboration! 

How are practices and institutions implementing it? What are some of the sticking points? What topics aren't being talked about enough? What should pharmacists be demanding out of various tests, trials and diagnoses? 

To identify and lead us through some of these important conversations, Ben and Matt are joined by HOPA members Mya Tran, PharmD, BCOP, a Precision Genomics Oncology Clinical Pharmacist at Indiana University Health's Simon Comprehensive Cancer Center in Indianapolis; and Noor Naffakh, PharmD, MS, BCOP, a Clinical Assistant Professor in the Department of Pharmacy Practice at the Retzky College of Pharmacy at the University of Illinois Chicago.

Find out more about HOPA’s Precision Oncology Initiative here: https://www.hoparx.org/resources/precision-oncology-initiative/  

You can read the paper Noor mentions about Discordance Recommendation Rate and Drug Cost Avoidance here: https://pubmed.ncbi.nlm.nih.gov/36265115/  

Noor refers to a joint program between HOPA and ACCP for a certificate in Oncology Genomics – the credits for this live program have since expired, but we may provide a future opportunity like this. Find out more here: https://www.accp.com/education/oncgx26/  

You can also learn about a past program similar to this that ACCP offered here: https://www.accp.com/education/pgx/  

Find out more about Trial GPT here: https://www.ncbi.nlm.nih.gov/research/trialgpt/  

Noor featured in one of the videos from our Time To Talk: Diversity in Clinical Trials campaign, discussing Biomarkers. It can be viewed here: https://www.youtube.com/watch?v=qQkSjG9WIYA 

Interested in contributing to a future episode? Got a topic suggestion? We'd love to hear from you. Email us at ⁠⁠⁠⁠[email protected]⁠

More episodes from "HOPA Now"